<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="225039">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00152724</url>
  </required_header>
  <id_info>
    <org_study_id>CP96-04</org_study_id>
    <nct_id>NCT00152724</nct_id>
  </id_info>
  <brief_title>Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers</brief_title>
  <official_title>Etude de la Reserve Vasomotrice Microcirculatoire cutanée</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Microvascular dysfunctions are critical events in several diseases including diabetes. This
      study will develop a methodology for microvascular investigation in human skin. The purpose
      of the study is to investigate the physiological response of the cutaneous microcirculation
      to physical, thermal, mechanical or chemical stimulations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study has investigated various aspects of the physiology of the microcirculation in the
      past years and is still recruiting under parallel protocols of physiological investigations
      of the neurovascular control of the cutaneous microcirculation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 1996</start_date>
  <completion_date type="Anticipated">January 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitude of the vasomotor response to stimuli</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kinetics of the vasomotor response to stimuli</measure>
  </secondary_outcome>
  <enrollment>85</enrollment>
  <condition>Healthy Volunteers</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pressure strain system, iontophoresis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>scopolamin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>emla</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>capsaicin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aspirin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clopidogrel</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>indomethacin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetylcholine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium nitroprusside</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>brethyllium</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>general and local heating</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers with no clinical signs of, or risk factors for, vascular disease

        Exclusion Criteria:

          -  Smokers, Pregnancy, Allergy,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis SAUMET, MD - PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre ABRAHAM, MD, PhD</last_name>
    <phone>(0)2-41-35-46-17</phone>
    <phone_ext>33</phone_ext>
    <email>piabraham@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Laboratoire de Physiologie et Explorations Vasculaires - CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre ABRAHAM, MD, PhD</last_name>
      <phone>(0)2-41-35-46-17</phone>
      <phone_ext>33</phone_ext>
      <email>piabraham@chu-angers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Tartas M, Durand S, Koïtka A, Bouyé P, Saumet JL, Abraham P. Anodal current intensities above 40 microA interfere with current-induced axon-reflex vasodilatation in human skin. J Vasc Res. 2004 May-Jun;41(3):261-7. Epub 2004 May 19.</citation>
    <PMID>15153776</PMID>
  </results_reference>
  <results_reference>
    <citation>Durand S, Fromy B, Humeau A, Sigaudo-Roussel D, Saumet JL, Abraham P. Break excitation alone does not explain the delay and amplitude of anodal current-induced vasodilatation in human skin. J Physiol. 2002 Jul 15;542(Pt 2):549-57.</citation>
    <PMID>12122152</PMID>
  </results_reference>
  <results_reference>
    <citation>Tartas M, Bouyé P, Koïtka A, Durand S, Gallois Y, Saumet JL, Abraham P. Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade. Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1668-73. Epub 2004 Nov 24.</citation>
    <PMID>15563538</PMID>
  </results_reference>
  <results_reference>
    <citation>Durand S, Tartas M, Bouyé P, Koïtka A, Saumet JL, Abraham P. Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans. J Physiol. 2004 Dec 15;561(Pt 3):811-9. Epub 2004 Oct 21.</citation>
    <PMID>15498811</PMID>
  </results_reference>
  <results_reference>
    <citation>Durand S, Fromy B, Tartas M, Jardel A, Saumet JL, Abraham P. Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators. Am J Physiol Regul Integr Comp Physiol. 2003 Jul;285(1):R155-61.</citation>
    <PMID>12793996</PMID>
  </results_reference>
  <results_reference>
    <citation>Durand S, Fromy B, Koïtka A, Tartas M, Saumet JL, Abraham P. Oral single high-dose aspirin results in a long-lived inhibition of anodal current-induced vasodilatation. Br J Pharmacol. 2002 Oct;137(3):384-90.</citation>
    <PMID>12237259</PMID>
  </results_reference>
  <results_reference>
    <citation>Durand S, Fromy B, Bouyé P, Saumet JL, Abraham P. Vasodilatation in response to repeated anodal current application in the human skin relies on aspirin-sensitive mechanisms. J Physiol. 2002 Apr 1;540(Pt 1):261-9.</citation>
    <PMID>11927685</PMID>
  </results_reference>
  <verification_date>March 2007</verification_date>
  <lastchanged_date>March 16, 2007</lastchanged_date>
  <firstreceived_date>September 8, 2005</firstreceived_date>
  <keyword>Physiology</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Laser-Doppler Flowmetry</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Acetylcholine</mesh_term>
    <mesh_term>Capsaicin</mesh_term>
    <mesh_term>Indomethacin</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Nitroprusside</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
